Fill Out Your Profile to share more about you. Learn more...

FDA Approves Keytruda for Early-Stage TNBC

Options
moderators
moderators Posts: 7,928
FDA Approves Keytruda for Early-Stage Triple-Negative Breast Cancer
July 27, 2021

The U.S. Food and Drug Administration (FDA) has approved Keytruda plus chemotherapy before surgery, followed by Keytruda alone after surgery to treat early-stage triple-negative breast cancer with a high risk of recurrence. Read more...